Evidence map›Paper›PMID 26065472›Full record

ArticleImmunotherapy2015

Advances and prospects in adoptive cell transfer therapy for ovarian cancer.

Katarzyna Urbanska, Daniel J Powell

Open access · greenAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Trial
  2. Article
  3. Cell therapies in ovarian cancer.Therapeutic advances in medical oncology · 2021
    Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Katarzyna UrbanskaOvarian Cancer Research Center, Department of Obstetrics & Gynecology, University of Pennsylvania, 3400 Civic Center Blvd, Bldg. 421, Philadelphia, PA 19104-5156, USA.
Daniel J PowellOvarian Cancer Research Center, Department of Obstetrics & Gynecology, University of Pennsylvania, 3400 Civic Center Blvd, Bldg. 421, Philadelphia, PA 19104-5156, USA.
Cancer Research Center · US

Funding

Therapeutic Micro RNA Strategies for Ovarian CancerP50CA083638 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI GODWIN, ANDREW K., GOLEMIS, ERICA A. · 1999 to 2013
$33.6M
A Universal Approach to Personalized Adoptive T cell Therapy of CancerR01CA168900 · NCI · UNIVERSITY OF PENNSYLVANIA · PI POWELL, DANIEL J. · 2012 to 2016
$1.6M
NCI NIH HHS P50 CA083638NCI NIH HHS R01 CA168900NCI NIH HHS R01-CA168900
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adoptive TransferFemaleHumansOvarian NeoplasmsPortraits as TopicT-Lymphocytesadoptive T-cell therapychimeric antigen receptorgene engineeringimmunotherapyovarian cancerTCRTILs

Identifiers

PMID26065472
PMCPMC4851244
OpenAlexW2103477314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.